Daniel Tassé is a businessperson who has been at the helm of 5 different companies.
He occupies the position of Chief Executive Officer & Executive Director at DBV Technologies SA.
He is also on the board of BioQ Pharma, Inc., REGENXBIO, Inc. and Roundtable On Critical Care Policy.
In his past career he occupied the position of Director at Bellerophon Therapeutics, Inc., Senior Independent Director at Indivior PLC, Chairman & Chief Executive Officer at Alcresta Therapeutics, Inc., GM-Pharmaceuticals & Technologies Business Unit at Baxter International, Inc., Vice President & Regional Director-Australasia at GSK Plc, Member of Healthcare Leadership Council, Chairman, President & Chief Executive Officer at Ikaria, Inc., Chief Financial Officer for NRG Energy Ltd. and Director at Biotechnology Innovation Organization.
Mr. Tassé received an undergraduate degree from the University of Montréal.